Jennifer Berres - 07 Feb 2025 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP & Chief Human Res. Officer
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
07 Feb 2025
Net transactions value
-$816,721
Form type
4
Filing time
11 Feb 2025, 18:16:51 UTC
Previous filing
30 Jan 2025
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $752,630 +7,440 +40% $101.16 26,171 07 Feb 2025 Direct
transaction HCA Common Stock Options Exercise $603,520 +4,340 +17% $139.06 30,511 07 Feb 2025 Direct
transaction HCA Common Stock Tax liability $2,172,871 -6,747 -22% $322.05 23,764 07 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -7,440 -100% $0.000000 0 07 Feb 2025 Common Stock 7,440 $101.16 Direct F1
transaction HCA Stock Appreciation Right Options Exercise $0 -4,340 -100% $0.000000 0 07 Feb 2025 Common Stock 4,340 $139.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.
F2 The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.